share_log

UniQure shares are trading higher after the company announced that its Hemophilia B Gene Therapy is unlikely to be causing liver cancer which was earlier reported in one patient.

UniQure shares are trading higher after the company announced that its Hemophilia B Gene Therapy is unlikely to be causing liver cancer which was earlier reported in one patient.

在该公司宣布其血友病B基因疗法不太可能导致肝癌后,UnQure的股价上涨。早些时候,有报道称,这是一名患者患上的肝癌。
Benzinga ·  2021/03/30 01:20

UniQure shares are trading higher after the company announced that its Hemophilia B Gene Therapy is unlikely to be causing liver cancer which was earlier reported in one patient.

在该公司宣布其血友病B基因疗法不太可能导致肝癌后,UnQure的股价上涨。早些时候,有报道称,这是一名患者患上的肝癌。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发